| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 02/15/1991 | WO1991002800A1 Thylakoid targeting sequence |
| 02/15/1991 | CA2064903A1 Thylakoid targeting sequence |
| 02/13/1991 | EP0412841A1 Human thrombomodulin derivatives |
| 02/13/1991 | EP0412700A1 Method for isolating fetal cytotrophoblast cells |
| 02/13/1991 | EP0412105A1 Stem cell inhibitors |
| 02/12/1991 | US4992531 Production of proteins in active forms |
| 02/12/1991 | US4992373 Vectors and compounds for direct expression of activated human protein C |
| 02/12/1991 | US4992369 Fermentation process for glycopeptide antibiotic |
| 02/12/1991 | US4992367 Genetic engineering |
| 02/12/1991 | US4992271 Formulation for lipophilic IL-2 proteins |
| 02/12/1991 | CA2022983A1 Expression of a functional insect specific toxin gene in mammalian cells |
| 02/12/1991 | CA2022713A1 Human thrombomodulin derivatives |
| 02/12/1991 | CA1280080C Promoters for the expression of foreign genes in yeast, plasmids comprising them, and uses thereof for the production of polypeptides |
| 02/12/1991 | CA1280072C Antigens related to the aids virus glycoprotein envelope, especially precursors of this glycoprotein, methods for obtaining theses antigens and measures applied in these methods, applications of these antigens to the preparation of immunogen compositions or for the diagnosis of aids or related conditions |
| 02/07/1991 | WO1991001499A1 Method for detecting cirrhosis of the liver |
| 02/07/1991 | WO1991001380A1 Monoclonal antibodies directed against proteins involved in plaquettary functions, their applications as diagnostic and therapeutic agents |
| 02/07/1991 | WO1991001379A1 Method of transcriptionally modulating gene expression and of discovering chemicals capable of functioning as gene expression modulators |
| 02/07/1991 | WO1991001378A1 Monoclonal antibodies directed against the proenzymes of b-like cathepsine and their biological applications |
| 02/07/1991 | WO1991001335A1 IgG3 ANTIBODIES WITH SHORTENED HINGE REGION AND A COMPLEMENT ACTIVATION TEST |
| 02/07/1991 | WO1991001305A1 Modified bioluminescent proteins and their use |
| 02/07/1991 | WO1991001133A1 T cell receptor peptides as therapeutics for autoimmune and malignant disease |
| 02/07/1991 | DE3925183A1 Proteine mit tnf-wirkung Proteins with tnf-effective |
| 02/07/1991 | CA2064766A1 Modified bioluminescent proteins and their use |
| 02/06/1991 | EP0412050A1 Novel cytokines |
| 02/06/1991 | EP0411974A1 Monoclonal antibodies to a neurofibrillary tangle antigen |
| 02/06/1991 | EP0411946A2 DNA encoding human GP130 protein |
| 02/06/1991 | EP0411896A2 Growth medium and fermentation process |
| 02/06/1991 | EP0411893A2 Chimeric antibodies directed against a human glycoprotein antigen |
| 02/06/1991 | EP0411684A2 New antigenically active proteins/peptides, and feline infectious virus (FIPV)-vaccines |
| 02/06/1991 | EP0411678A1 Method for the production of erythropoietin |
| 02/06/1991 | EP0411582A1 Bacillus thuringiensis var. donegani and preparation or toxin obtained therefrom, endowed with insecticidal activity against coleoptera |
| 02/06/1991 | EP0411501A1 Optimized fermentation processes for the production of foreign proteins en E-coli |
| 02/06/1991 | EP0411323A2 Human and mouse retinoic acid receptors and genes encoding for them |
| 02/06/1991 | EP0411306A1 Procedure for the detection and/or quantitative determination of complement peptide C5a and/or C5a-des-arg |
| 02/06/1991 | EP0411096A1 Dna sequences coding for pth variants, pth variants, expression vector, bacterial host, use and therapeutic composition |
| 02/06/1991 | EP0411031A1 THE HUMAN C3b/C4b RECEPTOR (CR1) |
| 02/06/1991 | EP0411018A1 Detection, quantitation and classification of ras proteins in body fluids and tissues. |
| 02/06/1991 | EP0250501B1 A process for the preparation of a heat resistant non-bitter water-soluble peptide product, the product produced by the process, and nutrients, refreshments and dietetics comprising the product |
| 02/06/1991 | EP0200748B1 Human tumor necrosis factor |
| 02/05/1991 | WO1991002080A2 Monoclonal antibody to acetylated lysine residues in recombinant bovine somatotropin |
| 02/05/1991 | US4990452 Combining mutations for stabilization of subtilisin |
| 02/05/1991 | US4990446 Promoters for the expression of foreign genes in yeast, plasmids comprising them, and use thereof for the production of polypeptides |
| 02/05/1991 | US4990443 Testosterone-3-dimethyl-carboxymethoxime-peroxidase or estradiol-6-dimethyl-carboxymethoxime peroxidase |
| 02/03/1991 | WO1991002000A1 Il-2 deletion mutants |
| 02/03/1991 | CA2064696A1 Il-2 deletion mutants |
| 02/01/1991 | WO1991002076A1 Method for obtaining polypeptides in a cell-free system |
| 02/01/1991 | WO1991002075A1 Method for obtaining polypeptides in a cell-free translation system |
| 02/01/1991 | CA2022273A1 Chimeric antibodies directed against a human glycoprotein antigen |
| 02/01/1991 | CA2022109A1 Enhanced expression of heterologous proteins in recombinant hosts in a non-growth media |
| 02/01/1991 | CA2022108A1 Enhanced growth and expression of heterologous proteins in recombinant hosts containing mutations in cell wall and/or plasma membrane biosynthesis |
| 01/31/1991 | DE4021979A1 Isolation of annexin protein(s) from cell lysate(s) |
| 01/31/1991 | DE3923951A1 Verfahren zum nachweis von leberzirrhose A method for detecting liver cirrhosis |
| 01/30/1991 | WO1991001998A1 Proteins with tnf activity |
| 01/30/1991 | EP0410813A1 Anti-human BCDF monoclonal antibody and immunoassay using the same |
| 01/30/1991 | EP0410751A2 Gene encoding M-CSF and related recombinant systems thereof |
| 01/30/1991 | EP0410750A2 Use of Interleukin-4 for increasing numbers of neutrophils and for treating myeloid or monocytoid leukaemia. |
| 01/30/1991 | EP0410713A1 Polypeptide inhibitor of viral replication |
| 01/30/1991 | EP0410655A1 Improved control of expression of heterologous genes from lac operated promoters |
| 01/30/1991 | EP0410638A2 Method for producing polyglutamic acid or a salt thereof |
| 01/30/1991 | EP0410303A1 Monoclonal antibody to endothelin-3 or precursor thereof and use thereof |
| 01/30/1991 | EP0410246A1 Erythropoietin(EPO)-peptides and antibodies against them |
| 01/30/1991 | EP0410228A1 The thermo-inducible expression of heterologous genes in bacillus subtilis and means and methods for its achievement |
| 01/30/1991 | EP0410061A1 Process for the treatment and decolorisation of protein solutions containing pigments from the groups haemo and chlorophyll, and products obtained |
| 01/30/1991 | EP0409963A1 Immunoassay for fast homoarginine-sensitive alkaline phosphatase (fhap) and antibody useful therewith |
| 01/30/1991 | EP0409923A1 EXPRESSION OF THE i(PLASMODIUM) CIRCUMSPOROZOITE PROTEIN IN INSECT CELLS |
| 01/30/1991 | EP0409901A1 Lak cell cytotoxin |
| 01/30/1991 | EP0409892A1 Combining mutations for stabilization of subtilisin |
| 01/30/1991 | EP0177531B1 Antibodies, manufacture and use |
| 01/30/1991 | CA2051124A1 Proteins with tnf activity |
| 01/29/1991 | WO1991002077A1 Efficient directional genetic cloning system |
| 01/29/1991 | US4988798 Method for recovering recombinant proteins |
| 01/29/1991 | US4988622 Recombinant plasmid DNA pVN 22 coding biosynthesis of human leukocyte interferon alpha-I1 and strain Pseudomonas sp. 31 (pVN 22) - producer of human leukocyte interferon alpha-I1 containing same |
| 01/29/1991 | CA2022185A1 Separation of anti-metal chelate antibodies |
| 01/29/1991 | CA1279591C High level production of bovine growth hormone |
| 01/28/1991 | CA2022135A1 The thermo-inducible expression of heterologous genes in bacillus subtilis and means and methods for its achievement |
| 01/28/1991 | CA2020106A1 Control of expression of heterologous genes from lac promotors |
| 01/27/1991 | WO1991001990A1 Chimeric anti-cea antibody |
| 01/26/1991 | WO1991001329A1 Polypeptide inhibitor of viral replication |
| 01/26/1991 | WO1991001145A1 Pokeweed antiviral protein - monoclonal antibody conjugates |
| 01/26/1991 | CA2063801A1 Polypeptide inhibitor of viral replication |
| 01/25/1991 | WO1991001374A1 Prevention of internal initiation |
| 01/25/1991 | CA2063799A1 Prevention of internal initiation |
| 01/25/1991 | CA2021779A1 Monoclonal antibody to endothelin-3 or precursor thereof and use thereof |
| 01/24/1991 | WO1991000921A1 Fragments of monoclonal antibodies specific to the presence of activated leucocytes, process for obtaining them and their application in the case of a transplant being rejected |
| 01/24/1991 | WO1991000920A2 Process for preparing a protein by a fungus transformed by multicopy integration of an expression vector |
| 01/24/1991 | WO1991000919A1 Promoters of colony stimulating factor activity |
| 01/24/1991 | WO1991000916A2 Receptors for fibroblast growth factors |
| 01/24/1991 | WO1991000913A1 Inducible expression vectors |
| 01/24/1991 | WO1991000906A1 Chimeric and transgenic animals capable of producing human antibodies |
| 01/24/1991 | WO1990015877A3 Methods, compositions and devices for growing cells |
| 01/24/1991 | WO1990014426A3 Saf polypeptide, gene, promoter and use for expression in streptomyces |
| 01/24/1991 | CA2035861A1 Promoters of colony stimulating factor activity |
| 01/23/1991 | EP0409607A2 Antibody to human interleukin-6 receptor |
| 01/23/1991 | EP0409472A1 Bone morphogenetic protein |
| 01/23/1991 | EP0409294A1 Cofactor for the PAM enzyme |
| 01/23/1991 | EP0409242A1 Monoclonal antibody against human CD4 peptide |
| 01/23/1991 | EP0409156A1 Fused yeast for foreign protein expression, methods of producing said yeast and methods of producing foreign proteins |
| 01/23/1991 | EP0409113A1 Human erythropoietin muteins, their production and their use |
| 01/23/1991 | EP0409091A1 Antagonists of GM-CSF derived from the carboxyl terminus |
| 01/23/1991 | EP0409053A1 Process for purifying annexins |